-
Isoproterenol Sulfate Dihydrate in SAN Assays
2026-09-17
Use Isoproterenol sulfate dihydrate as a controlled beta-adrenergic challenge in human SAN-plexus assembloids, separating acute receptor responsiveness from innervation-driven pacemaker maturation. This workflow links dose, timing, electrophysiology, and cAMP/PKA readouts for more interpretable cardiovascular research.
-
EZ Cap™ OVA mRNA Workflow Guide
2026-09-17
Learn how to use EZ Cap™ OVA mRNA as a consistent Ovalbumin mRNA immunogen for gene expression studies, airway models, and vaccine development research. The workflow connects Cap 1 transcript quality with delivery-system selection, inflammation controls, and practical troubleshooting.
-
AM 281: CB1 Antagonist Workflow for TBI Research
2026-09-16
AM 281 gives researchers a selective way to interrogate CB1-dependent control of astrocytic GLT-1, neuronal survival, and cognitive readouts after traumatic brain injury. This workflow translates the CB1-CREB-GLT-1 findings into practical formulation, assay design, controls, and troubleshooting decisions.
-
Atorvastatin Workflows for Metabolic Research
2026-09-15
Atorvastatin supports controlled studies of cholesterol metabolism, vascular phenotypes, and emerging ferroptosis biology. This practical guide connects concentration selection, assay design, formulation, and troubleshooting with findings from a recent hepatocellular carcinoma study.
-
Annexin V-APC/7-AAD Apoptosis Kit Workflow
2026-09-15
Build a rapid, dual-parameter workflow for separating viable, apoptotic, and necrotic cells in cancer and immune-cell experiments. The assay combines cell-surface phosphatidylserine exposure with membrane-integrity readout, making it especially useful for mechanism-focused studies such as the PSA-CD56/Siglec-7 immune-evasion model.
-
Cefodizime Workflows for Antibacterial Research
2026-09-14
Build reproducible Cefodizime assays around PBP-directed killing, matrix-aware MIC testing, and carefully selected susceptible and resistant controls. The workflow also separates direct antibacterial effects from the compound’s reported immunomodulatory activity, helping researchers interpret respiratory, urinary, and host-response models more rigorously.
-
Isoproterenol Sulfate Dihydrate: Assay Guide
2026-09-14
This scenario-based guide explains how Isoproterenol sulfate dihydrate (SKU C6402) can support controlled beta-adrenergic receptor signaling studies alongside cell viability, proliferation, and cytotoxicity assays. It covers assay compatibility, solution preparation, data interpretation, storage, and practical vendor-selection criteria.
-
WEHI-539 and the Logic of BCL-XL Dependency
2026-09-13
A translational framework for using WEHI-539 to distinguish BCL-XL-dependent apoptosis from broader stress responses, with implications for cancer stem cell sensitization, chemoresistance, and rational experimental design.
-
Acetoacetic Acid Sodium Salt in Metabolic Assays
2026-09-12
Acetoacetic acid sodium salt provides a water-compatible way to model ketone-body exposure, build matrix-spike controls, and investigate fatty acid catabolism. This workflow-focused guide covers dosing design, LC-MS assay preparation, controls, and troubleshooting for reproducible energy metabolism research.
-
BGJ398 Workflows for FGFR Signaling Research
2026-09-12
BGJ398 (NVP-BGJ398) enables selective interrogation of FGFR1/2/3 signaling in cancer models, while its pathway-focused profile also supports carefully controlled developmental assays. This guide translates the compound’s biochemical selectivity into practical dosing, readout, troubleshooting, and cross-model validation strategies.
-
Arrb2–6-ketoLCA Axis in Liver IRI
2026-09-11
The reference study identifies hepatocyte Arrb2 as an upstream regulator of the metabolite 6-ketoLCA, linking hepatocyte stress responses to M2 macrophage polarization during hepatic ischemia–reperfusion injury. Its combination of clinical samples, hepatocyte-focused mouse models, hypoxia–reoxygenation systems, and metabolomics provides a mechanistic framework for studying immune–metabolic control of liver graft injury.
-
Collagen VI ECM Scaffolds Mature iPSC Islet Organoids
2026-09-11
Zhu and colleagues show that decellularized amniotic membrane ECM supports the viability, maturation, endocrine function, and engraftment of iPSC-derived islet organoids. Their analysis identifies collagen VI as a key niche component and provides a biomimetic scaffold strategy for improving organoid transplantation research.
-
Cycloheximide Workflows for Protein Turnover
2026-09-10
Cycloheximide provides a fast way to pause eukaryotic translation and distinguish protein synthesis from protein stability. This practical guide connects dose-finding, apoptosis assay design, and protein turnover measurements to the WWP2–DDX3X mechanism reported in diabetic endothelial injury.
-
Trametinib as a MEK-ERK Pathway Probe
2026-09-10
Trametinib (GSK1120212) provides a precise way to interrogate MEK-ERK signaling beyond conventional oncology assays. This article explains how its use as a pathway-intervention probe can clarify BH4 oxidation, H2O2, and ERK1/2 activation in sensory-neuron research while preserving rigorous assay boundaries.
-
α-Bungarotoxin: Nicotinic Receptor Blockade
2026-09-09
α-Bungarotoxin is a selective α7 nicotinic acetylcholine receptor antagonist used for nicotinic receptor blockade in neuroscience research and cholinergic signaling studies. In a rat placental ischemia model, α-bungarotoxin eliminated pyridostigmine-associated effects, supporting α7 nAChR dependence without establishing clinical efficacy.